DSM-Firmenich hosts 600-delegate forum: DSM-Firmenich stock sits 1.50 percent below its high

Published on 10/27/2026 at 09:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The company named two firms October 22, retaining 20.00 percent. DSM-Firmenich stock costs EUR 108.20 on October 27, 2026, below EUR 109.85 high.

Leadership and portfolio transition

More than 600 delegates attended the World Nutrition Forum on October 26, 2026.
dsm-firmenich retained 20.00 percent in each future company named on October 22, 2026.
DSM-Firmenich stock trades at EUR 108.20 at 9:36 a.m. CEST at Lang & Schwarz on October 27, 2026.
The company had a market capitalization of EUR 26.2 billion as of October 27, 2026.

DSM-Firmenich, CH1216478797, Illustration mit AI erstellt.

DSM-Firmenich (ISIN CH1216478797) brought more than 600 delegates together at its World Nutrition Forum in Kuala Lumpur on October 26, 2026, as the company prepares its Animal Nutrition and Health business for a new structure. The dsm-firmenich press release said the two-day event focused on science, digital technologies, sustainability and animal nutrition.

Two future companies take shape

The forum followed the company announcement of October 22, 2026, which named Noviwest and Panavora as the two standalone companies intended to emerge from the sale of Animal Nutrition and Health to CVC Capital Partners. Under the planned structure, dsm-firmenich will retain a 20.00 percent equity interest in each company, while completion remains subject to regulatory approvals, employee consultation and other transaction conditions.

Noviwest will focus on vitamins, carotenoids and aroma ingredients. Panavora will combine premixes, feed additives, digital products and precision services for animal nutrition and health. The split gives the businesses separate strategies while allowing selected cooperation after completion, according to the company release.

What does the transition mean?

The immediate investor signal is structural rather than a completed disposal. Animal Nutrition and Health remains part of dsm-firmenich until the transaction closes, so the 20.00 percent retained stakes describe the intended ownership after completion rather than a completed transfer. The forum therefore connects the operating redesign with the companys broader nutrition, health and beauty portfolio.

Stock stays near its yearly high

The stock stood 1.50 percent below its EUR 109.85 52-week high, using the current euro quote and the same-currency range. The finance quote showed a market capitalization of EUR 26.2 billion as of October 27, 2026, while the 52-week range ran from EUR 55.22 to EUR 109.85.

DSM-Firmenich was trading at EUR 108.20 at Lang & Schwarz on October 27, 2026 at 9:36 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of DSM-Firmenich stock.